Oleanz Forte Tablet contains a combination of Fluoxetine 20mg and Olanzapine 10mg, formulated to manage complex psychiatric conditions such as treatment-resistant depression and bipolar disorder. Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), functions by increasing serotonin levels in the brain, thereby improving mood, appetite, and energy levels while reducing anxiety and depressive symptoms. Olanzapine, an atypical antipsychotic, modulates the activity of various neurotransmitters including dopamine and serotonin, helping to stabilize mood, reduce psychotic symptoms, and prevent manic episodes. The synergistic effect of these two agents provides enhanced therapeutic benefits in patients who have not responded adequately to monotherapy. Oleanz Forte is indicated for the treatment of major depressive disorder with psychotic features, bipolar depression, and schizoaffective disorders. It should be administered under strict medical supervision due to potential side effects such as weight gain, sedation, metabolic changes, and extrapyramidal symptoms. Regular monitoring of blood glucose, lipid profile, and liver function tests is recommended during prolonged therapy. Dosage adjustments must be individualized based on clinical response and tolerability. Patients should avoid abrupt discontinuation to prevent withdrawal symptoms. Oleanz Forte offers a comprehensive approach to managing complex mood disorders by targeting multiple neurochemical pathways.